Graduate School of Medical Sciences News

A new technology allows scientists to map, in single cells, the DNA binding sites of transcription factors and other regulatory proteins that control gene activity, according to a study led by investigators at Weill Cornell Medicine and the New York Genome Center.

Weill Cornell Medicine received a five-year, $5 million grant from the National Cancer Institute, part of the National Institutes of Health, to develop innovative support strategies for an understudied group of cancer patients: adolescents and young adults (AYAs).

Obtaining home care for older adults with Medicaid can be a complex, multi-step process marked by delays and uncertainty, often resulting in long wait times, according to a new Weill Cornell Medicine study.

According to a new preclinical study by Weill Cornell Medicine and MD Anderson Cancer Center investigators, colorectal tumors often find multiple ways to survive treatment, including additional genetic mutations and activation of cellular pathways typically associated with inflammation and regeneration. 

Weill Cornell Graduate School of Medical Sciences honored the 311 expected Class of 2026 graduates May 14 during the school’s first dedicated Commencement ceremony.

Weill Cornell Graduate School of Medical Sciences celebrated students in the Class of 2026 for their academic achievements during its convocation ceremony on May 13.

Weill Cornell Medicine investigators studying a bacterial protein have identified a new mechanism of sensing cold temperatures. 

A pilot program aimed at reducing Medicaid drug spending has limitations, according to a multi-institutional research team including faculty from Weill Cornell Medicine.

Weill Cornell Medicine investigators have “reverse engineered” ketamine’s antidepressant effects to identify potential new strategies for treating depression.

While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in arrests still exist, according to a new study led by Weill Cornell Medicine. 

The 45th annual Vincent du Vigneaud Memorial Research Symposium, a student-organized event that has become central to the Weill Cornell Graduate School of Medical Sciences experience, had a record number of 153 abstracts submitted this year, including posters and eight oral presentations.

Nerve fibers within melanomas can slow the growth of these tumors, according to a study led by Weill Cornell Medicine investigators. 

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.” 

Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate chronic inflammation in the intestine, potentially opening new avenues for therapies against inflammatory bowel disease (IBD), food allergy and other autoimmune conditions.

A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot soldier in the body’s defense against bacterial infection, does not actually help clear invaders the way its close cousin caspase-4 (CASP4) does.

Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein that has essential roles in all animals. 

Temporarily disabling a protein complex that organizes DNA into loops inside the cell’s nucleus drastically disrupted the three-dimensional structure of the genome, but surprisingly most genes continued to function as usual, Weill Cornell Medicine researchers found. 

As states reassess Medicaid coverage following recent federal policy changes and the end of pandemic-era protections, researchers at Weill Cornell Medicine’s Department of Pediatrics, the Cornell Health Policy Center and Ariadne Labs are championing evidence-based health care policy reform and expanded Medicaid coverage for children. 

A $1 million Research Scholar Grant from the American Cancer Society will help a multi-institution team led by Dr. Bishoy Faltas, associate professor of medicine at Weill Cornell Medicine, to develop new therapy combinations for hard-to-treat urinary tract cancers.

Leaders in the field discussed a shift in research toward looking at shared mechanisms in neurodegenerative diseases at the recent 13th annual Helen and Robert Appel Alzheimer’s Disease Research Institute Symposium held in the Belfer Research Building at Weill Cornell Medicine.